Efficacy and Safety of Once ‐weekly Dulaglutide Versus Insulin Glargine in Mainly Asian Patients with Type 2 Diabetes Mellitus on Metformin and/or a Sulfonylurea: a 52‐week Open‐label, Randomized Phase 3 Trial

Diabetes, Obesity and Metabolism,Volume 0, Issue ja, -Not available-.

Source: Diabetes, Obesity and Metabolism - August 21, 2018 Category: Endocrinology Authors: Weiqing Wang MD , Luis Nevarez Ruiz MD , Ekaterina Filippova MD , Ki Ho Song MD , Bei Tao MD , Liqun Gu MD , Feng Wang MD , Pengfei Li PhD , Jun Yang MD Source Type: research